APT Medical is a technology company.
APT Medical has raised $61.0M across 4 funding rounds.
APT Medical has raised $61.0M in total across 4 funding rounds.
APT Medical is a technology-driven medical device company specializing in the design, manufacture, and supply of advanced Electrophysiology (EP) and Vascular Intervention devices. Its product portfolio spans Electrophysiology, Cardiology, Peripheral, and Neurointervention, serving healthcare providers such as clinicians, hospitals, and academic institutions worldwide. The company focuses on solving complex clinical challenges by delivering innovative, reliable tools that improve patient outcomes and procedural efficiency. Over more than two decades, APT Medical has demonstrated consistent growth and a commitment to advancing interventional medicine through technology and collaboration with medical experts[1][2][4].
Founded in 2002, APT Medical emerged from a vision to advance interventional medicine by leveraging technological innovation and clinical collaboration. The company was built on the expertise of engineers, clinicians, and marketers working together to develop cutting-edge solutions for cardiovascular and neurological interventions. Early traction came from its success in PCI (Percutaneous Coronary Intervention) solutions, which laid the foundation for expanding into peripheral and neurovascular interventions. This collaborative and innovation-driven approach has been central to its evolution and sustained leadership in the medical device industry[1][2].
APT Medical rides the wave of increasing demand for minimally invasive, precision interventional therapies driven by aging populations and rising cardiovascular and neurological disease prevalence. The timing is favorable due to advances in materials science, manufacturing, and digital health integration, which enable safer, faster, and more effective procedures. Market forces such as healthcare cost containment and the push for better patient outcomes further support adoption of APT Medical’s innovations. By advancing electrophysiology and vascular intervention technologies, APT Medical influences the broader ecosystem by enabling clinicians to tackle complex cases with improved confidence and efficiency, thus pushing forward the standard of care in interventional medicine[1][2][4].
APT Medical is poised to continue its trajectory as a leader in interventional medical devices by expanding its innovative product lines and global footprint. Trends shaping its journey include the growing adoption of pulsed-field ablation and 3D mapping technologies, as well as integration with digital health platforms for enhanced diagnostics and treatment monitoring. Its influence is likely to grow as it fosters deeper clinical partnerships and leverages emerging technologies to address unmet medical needs. The company’s commitment to innovation, clinical collaboration, and global expansion positions it well to shape the future of minimally invasive cardiovascular and neurovascular care[4].
APT Medical has raised $61.0M in total across 4 funding rounds.
APT Medical's investors include Qiming Venture Partners.
APT Medical has raised $61.0M across 4 funding rounds. Most recently, it raised $27.0M Venture Round in August 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2019 | $27.0M Venture Round | Qiming Venture Partners | |
| Oct 1, 2018 | $19.0M Series C | Qiming Venture Partners | |
| Jul 1, 2018 | $11.0M Series B | Qiming Venture Partners | |
| Sep 1, 2016 | $4.0M Series A | Qiming Venture Partners |